Health

FDA Grants Accelerated Approval to Avmapki Fakzynja Co-Pack (avutometinib capsules/defactinib tablets) for KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer

DailyTrendDailyTrend
May 13, 2025 - 09:00
 0  0
FDA Grants Accelerated Approval to Avmapki Fakzynja Co-Pack (avutometinib capsules/defactinib tablets) for KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer
BOSTON--(BUSINESS WIRE)--May 8, 2025-- Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that the U.S. Food and Drug Administration...
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

Early Alert: Cardiac Cannula Issue from Medtronic

Early Alert: Cardiac Cannula Issue from Medtronic

DailyTrend Aug 16, 2025  0  0

FDA Approves Papzimeos (zopapogene imadenovec-drba) for the Treatment of Adults with Recurrent Respiratory Papillomatosis

FDA Approves Papzimeos (zopapogene imadenovec-drba) for...

DailyTrend Aug 18, 2025  0  0

What to Know About Plague After a New Case in California

What to Know About Plague After a New Case in California

DailyTrend Aug 22, 2025  0  0

A 1990 Measles Outbreak Shows How the Disease Can Roar Back

A 1990 Measles Outbreak Shows How the Disease Can Roar ...

DailyTrend Aug 21, 2025  0  0

Trump’s Get-Tough Approach on Homelessness May Sweep Up Veterans

Trump’s Get-Tough Approach on Homelessness May Sweep Up...

DailyTrend Aug 19, 2025  0  0

How Medicaid Cuts Could Force Disabled Americans Into Institutions

How Medicaid Cuts Could Force Disabled Americans Into I...

DailyTrend Aug 20, 2025  0  0